Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, Double Blind, Placebo Controlled Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

NCT00717093 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00717093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00717093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, Double Blind, Placebo Controlled Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2008
Completion date
July 31, 2009
Enrollment
432 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use cessation